FDA
approval
· 2012-12-05
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
The FDA approved a supplemental application for Macleods Pharmaceuticals Limited to market Irbesartan and Hydrochlorothiazide as a fixed-dose combination for th…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)